Follow The Filings

HCWB HCW Biologics

HCW Biologics earnings company data as of 4:48 AM ET 10/23

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 13 Nov EPS — — —
Rev — — —
FY2026 Q2 14 Aug EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by HCWB's executives, directors and 10% owners in the last 12 months, from their Form 4s

All HCWB insider trades
  • $530K bought by 4 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Hing C Wong CEO
    Buy
    $60K 23,210 shares at $2.59 +23% to stake
    Traded Jul 29 Filed Jul 31
    ↗
  2. Lee Flowers SVP of Business Development
    Buy
    $20K 7,736 shares at $2.59 +810% to stake
    Traded Jul 29 Filed Jul 31
    ↗
  3. Hing C Wong CEO
    Buy
    $160K 113,879 shares at $1.41 +23% to stake
    Traded May 22 Filed May 27
    ↗
  4. Scott T Garrett Director
    Buy
    $250K 177,936 shares at $1.41 +698% to stake
    Traded May 22 Filed May 27
    ↗
  5. Rebecca Byam CFO
    Buy
    $20K 14,235 shares at $1.41 +33% to stake
    Traded May 22 Filed May 27
    ↗

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
S-1 Filing Doc
DEF 14A Filing Doc
8-K 1.01,3.02,7.01,8.01,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 1.01,7.01,9.01 Filing Doc
S-1/A Filing Doc
S-1 Filing Doc
8-K 4.02 Filing Doc
10-Q/A Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 1.01,3.02,7.01,8.01,9.01 Filing Doc
8-K 8.01 Filing Doc
8-K 3.01,9.01 Filing Doc
8-K 3.03,5.03,7.01,9.01 Filing Doc
S-1/A Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 5.07 Filing Doc
S-1 Filing Doc
8-K 3.01 Filing Doc
8-K 1.02,9.01 Filing Doc
8-K 1.01,3.02,7.01,8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.